Tick-borne encephalitis

Antiviral Research

Volumn 57, Issue 1-2, 2003, Pages 129-146

  Gritsun, T S ^a   Lashkevich, V A ^b   Gould, E A ^a  

^a CENTRE FOR ECOLOGY AND HYDROLOGY   (United Kingdom)

^b CHUMAKOV INSTITUTE OF POLIOMYELITIS AND VIRAL ENCEPHALITIDES   (Russian Federation)

Author keywords

Bioterrorism; Biphasic milk fever; Chronic tick borne encephalitis; Live attenuated vaccine; Omsk hemorrhagic fever virus; Pathogenesis; Tick borne encephalitis virus

Indexed keywords

ADRENALIN; CYCLOPHOSPHAMIDE; GENOMIC RNA; IMMUNOSUPPRESSIVE AGENT; INACTIVATED VACCINE; LIVE VACCINE; PREDNISOLONE; VINCRISTINE; VIRUS DNA; VIRUS RNA;

ALKHURMA VIRUS; ASIA; CLINICAL FEATURE; CLINICAL TRIAL; CROSS REACTION; DRUG INDUCED DISEASE; DRUG SAFETY; EPIDEMIC; EUROPE; EXPERIMENTAL INFECTION; FLAVIVIRUS; HUMAN; IMMUNOGENICITY; IMMUNOPROPHYLAXIS; IMMUNOSTIMULATION; INFECTION PREVENTION; KYASANUR FOREST DISEASE VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; OMSK HEMORRHAGIC FEVER FLAVIVIRUS; PARTURIENT PARESIS; PHYLOGENY; PRIORITY JOURNAL; REVIEW; RUSSIAN FEDERATION; SPECIES COMPARISON; TICK BORNE ENCEPHALITIS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VIRION; VIRUS; VIRUS ENVELOPE; VIRUS EXPRESSION; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSMISSION;

ACARI; ALKHURMA VIRUS; FLAVIVIRIDAE; FLAVIVIRUS; KYASANUR FOREST DISEASE VIRUS; LANGAT VIRUS; LOUPING ILL VIRUS; OMSK HEMORRHAGIC FEVER VIRUS; POWASSAN VIRUS; TICK-BORNE ENCEPHALITIS VIRUS;

EID: 12244283132     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(02)00206-1     Document Type: Article

References (182)

1. 141, O.N., 1990. The Further Development of Measures to Improve Prophylactics of Tick-Borne Encephalitis. The Ministry of Healthcare of USSR, Moscow.
2. Aberle J.H., Aberle S.W., Allison S.L., Stiasny K., Ecker M., Mandl C.W., Berger R., Heinz F.X. A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms. J. Immunol. 163:1999;6756-6761.
3. Aihara S., Rao C.M., Yu Y.X., Lee T., Watanabe K., Komiya T., Sumiyoshi H., Hashimoto H., Nomoto A. Identification of mutations that occurred on the genome of Japanese encephalitis virus during the attenuation process. Virus Genes. 5:1991;95-109.
4. Alekseev A.N., Chunikhin S.P. The experimental transmission of the tick-borne encephalitis virus by ixodid ticks (the mechanisms, time periods, species and sex differences). Parazitologiia. 24:1990;177-185.
5. Allison S.L., Stiasny K., Stadler K., Mandl C.W., Heinz F.X. Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E. J. Virol. 73:1999;5605-5612.
6. Allison S.L., Schalich J., Stiasny K., Mandl C.W., Heinz F.X. Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J. Virol. 75:2001;4268-4275.
7. Amberg S.M., Rice C.M. Mutagenesis of the NS2B-NS3-mediated cleavage site in the flavivirus capsid protein demonstrates a requirement for coordinated processing. J. Virol. 73:1999;8083-8094.
8. Arroyo J., Guirakhoo F., Fenner S., Zhang Z.X., Monath T.P., Chambers T.J. Molecular basis for attenuation of neurovirulence of a Yellow fever virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J. Virol. 75:2001;934-942.
9. Barrett, P.M., Dorner, F., Plotkin, S.A., 1999. Tick-borne encephalitis vaccine. In: Plotkin, S.A., Orenstein, W.A. (Eds.), Vaccines. W.B. Saunders Company, Philadelphia, London, Toronto, Montreal, Sydney, Tokyo, A Division of Harcourt Brace and Company (Chapter 32), pp. 767-780.
10. Belov G.F., Tofaniuk E.V., Kurzhukov G.P., Kuznetsova V.G. The clinico-epidemiological characteristics of Omsk hemorrhagic fever in 1988-1992. Zh. Mikrobiol. Epidemiol. Immunobiol. 4:1995;88-91.
11. Blaskovic D., Pucekova G., Kubinyi L., Stupalova S., Oravcocva V. An epidemiological study of tick-borne encephalitis in the Tribec region: 1953-1963. Bull. World Health Org. 36:1967;89-94.
12. Burke, D.S., Monath, T.P., 2001. Flaviviruses. In: Knipe, D.M., Howley, P.M. (Eds.), Fields Virology, vol. 1. Lippincott Williams & Wilkins, London, New York, Tokyo, pp. 1043-1125.
13. Busygin F.F. Omsk hemorrhagic fever - current status of the problem. Vopr. Virusol. 45:2000;4-9.
14. Cahour A., Pletnev A., Vazielle Falcoz M., Rosen L., Lai C.J. Growth-restricted dengue virus mutants containing deletions in the 5′ noncoding region of the RNA genome. Virology. 207:1995;68-76.
15. Calisher C.H. Antigenic classification and taxonomy of flaviviruses (family Flaviviridae) emphasizing a universal system for the taxonomy of viruses causing tick-borne encephalitis. Acta Virol. 32:1988;469-478.
16. Cane P.A., Gould E.A. Reduction of Yellow fever virus mouse neurovirulence by immunization with a bacterially synthesized non-structural protein (NS1) fragment. J. Gen. Virol. 69:1988;1241-1246.
17. Cecilia D., Gould E.A. Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants. Virology. 181:1991;70-77.
18. Chambers T.J., Nestorowicz A., Rice C.M. Mutagenesis of the Yellow fever virus NS2B/3 cleavage site: determinants of cleavage site specificity and effects on polyprotein processing and viral replication. J. Virol. 69:1995;1600-1605.
19. Charrel R.N., Zaki A.M., Attoui H., Fakeeh M., Billoir F., Yousef A.I., de Chesse R., De Micco P., Gould E.A., de Lamballerie X. Complete coding sequence of the Alkhurma virus, a tick-borne flavivirus causing severe hemorrhagic fever in humans in Saudi Arabia. Biochem. Biophys. Res. Commun. 287:2001;455-461.
20. Chen H.W., Pan C.H., Liau M.Y., Jou R., Tsai C.J., Wu H.J., Lin Y.L., Tao M.H. Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines. J. Virol. 73:1999;10137-10145.
21. Chumakov M.P., Rubin S.G., Semashko I.V., Karavanov A.S., Avdeeva L.I., Gagarina A.V., Gambarian A.S., Matrosovich M.N., Mart'ianova L.I., Mironova L.L.et al. A new prospective vaccine against tick-borne encephalitis. Zh. Mikrobiol. Epidemiol. Immunobiol. 1:1991;36-40.
22. Chumakov M.P., Zyaitlenok N.A., Vorob'eva M.S. The studies of virus encephalitis. Report II. The geographical distribution and epidemiological characteristics of tick-borne encephalitis in European part of Soviet Union, Siberia and Kazachstan. Neuropathol. Psychiatry. 13:1944;20-23.
23. Cihak J., Lehmann-Grube F. Immunological tolerance to lymphocytic choriomeningitis virus in neonatally infected virus carrier mice: evidence supporting a clonal inactivation mechanism. Immunology. 34:1978;265-275.
24. Clarke D.H. Antigenic analysis of certain group B arthropod-borne viruses by antibody absorption. J. Exp. Med. 111:1960;25-36.
25. Davidson M.M., Williams H., Macleod J.A. Louping ill in man: a forgotten disease. J. Infect. 23:1991;241-249.
26. Dmitriev I.P., Khromykh A.A., Ignatyev G.M., Gainullina M.N., Ageenko A., Dryga S.A., Vorobyeva M.S., Sandakhchiev L.S. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis. J. Biotechnol. 44:1996;97-103.
27. dos Santos C.N., Post P.R., Carvalho R., Ferreira I.I., Rice C.M., Galler R. Complete nucleotide sequence of Yellow fever virus vaccine strains 17DD and 17D-213. Virus Res. 35:1995;35-41.
28. Dzhivanian T.I., Lashkevich V.A. The effect of sulfopolysaccharides on plaque formation by tick-borne encephalitis complex viruses with different neurovirulence. Vopr. Virusol. 15:1970;395-399.
29. Dzhivanian T.I., Lashkevich V.A., Bannova G.G., Sarmanova E.S., Chuprinskaya M.V., Vesenjak Hirjan J., Vince V. On the possible association of the DS marker of tick-borne encephalitis virus strains with species of tick vectors. Arch. Gesamte Virusforsch. 45:1974;209-214.
30. Dzhivanian T.I., Korolev M.B., Karganova G.G., Lisak M., Kashtanova G.M. Changes in the host-dependent characteristics of the tick-borne encephalitis virus during its adaptation to ticks and its readaptation to white mice. Vopr. Virusol. 33:1988;589-595.
31. Dzhivanian T.I., Karganova G.G., Sobolev S.G., Korolev M.B., Kashtanova G.M., Chuprinskaia M.V., Lashkevich V.A. The properties of the particles formed in the reproduction of an acute in vitro infection with the tick-borne encephalitis virus adapted to H. plumbeum ticks. Vopr. Virusol. 36:1991;297-300.
32. Ecker M., Allison S.L., Meixner T., Heinz F.X. Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia. J. Gen. Virol. 80:1999;179-185.
33. Falconar A.K. The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch. Virol. 142:1997;897-916.
34. Flamand M., Megret F., Mathieu M., Lepault J., Rey F.A., Deubel V. Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J. Virol. 73:1999;6104-6110.
35. Fokina G.I., Malenko G.V., Levina L.S., Koreshkova G.V., Rzhakhova O.E., Mamonenko L.L., Pogodina V., Frolova M.P. Persistence of tick-borne encephalitis virus in monkeys. V. Virus localization after subcutaneous inoculation. Acta Virol. 26:1982;369-375.
36. Frolova M.P., Pogodina V.V. Persistence of tick-borne encephalitis virus in monkeys. VI. Pathomorphology of chronic infection in central nervous system. Acta Virol. 28:1984a;232-239.
37. Frolova T.V., Pogodina V.V. Activating effect of adrenaline, prednisolone and vincristine in the late periods of tick-borne encephalitis virus persistence. Vopr. Virusol. 29:1984b;103-108.
38. Frolova M.P., Isachkova L.M., Shestopalova N.M., Pogodina V.V. Experimental monkey encephalitis caused by Powassan virus. Zh. Nevropatol. Psikhiatr. 81:1981;25-33.
39. Frolova T.V., Pogodina V.V., Frolova M.P., Karmysheva V. Characteristics of long-term persisting strains of tick-borne encephalitis virus in different forms of the chronic process in animals. Vopr. Virusol. 27:1982a;473-479.
40. Frolova T.V., Pogodina V.V., Larina G.I., Frolova M.P., Karmysheva V. Activating effect of cyclophosphane at late stages of persistence of the tick-borne encephalitis virus. Vopr. Virusol. 27:1982b;66-73.
41. Frolova M.P., Isachkova L.M., Shestopalova N.M., Pogodina V.V. Experimental encephalitis in monkeys caused by the Powassan virus. Neurosci. Behav. Physiol. 15:1985;62-69.
42. Fugier Vivier I., Servet Delprat C., Rivailler P., Rissoan M.C., Liu Y.J., Rabourdin Combe C. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J. Exp. Med. 186:1997;813-823.
43. Gagnon S.J., Zeng W., Kurane I., Ennis F.A. Identification of two epitopes on the dengue 4 virus capsid protein recognized by a serotype-specific and a panel of serotype-cross-reactive human CD4+ cytotoxic T-lymphocyte clones. J. Virol. 70:1996;141-147.
44. Gao G.F., Hussain M.H., Reid H.W., Gould E.A. Classification of a new member of the TBE flavivirus subgroup by its immunological, pathogenetic and molecular characteristics: identification of subgroup-specific pentapeptides. Virus Res. 30:1993;129-144.
45. Gao G.F., Hussain M.H., Reid H.W., Gould E.A. Identification of naturally occurring monoclonal antibody escape variants of louping ill virus. J. Gen. Virol. 75:1994;609-614.
46. Gaunt M.W., Sall A.A., de Lamballerie X., Falconar A.K., Dzhivanian T.I., Gould E.A. Phylogenetic relationships of flaviviruses correlate with their epidemiology, disease association and biogeography. J. Gen. Virol. 82:2001;1867-1876.
47. Gould E.A. Virus cryopreservation and storage. Meth. Mol. Biol. 38:1995;7-20.
48. Gould E.A., Buckley A., Barrett A.D.T., Cammack N. Neutralizing (54-kilodalton) and non-neutralizing (54-kilodalton and 48-kilodalton) monoclonal antibodies against structural and non-structural Yellow fever virus proteins confer immunity in mice. J. Gen. Virol. 67:1986;591-595.
49. Gould E.A., de Lamballerie X., Zanotto P.M.A., Holmes E.C. Evolution, epidemiology and dispersal of flaviviruses revealed by molecular phylogenies. Adv. Virus Res. 57:2001;71-103.
50. Gresikova, M. Calisher, C.H., 1988. Tick-borne encephalitis. In: Monath, T.P. (Ed.), The Arboviruses: Ecology and Epidemiology, vol. IV. CRC Press, Boca Raton, FL, pp. 177-203.
51. Gresikova M., Sekeyova M., Stupalova S., Necas S. Sheep milk-borne epidemic of tick-borne encephalitis in Slovakia. Intervirology. 5:1975;57-61.
52. Gresikova-Kohutova M. Effect of pH on infectivity of the tick-borne encephalitis virus. Acta Virol. 3:1959;159-167.
53. Gritsun T.S., Gould E.A. Infectious transcripts of tick-borne encephalitis virus, generated in days by RT-PCR. Virology. 214:1995;611-618.
54. Gritsun T.S., Gould E.A. Development and analysis of a tick-borne encephalitis virus infectious clone using a novel and rapid strategy. J. Virol. Meth. 76:1998;109-120.
55. Gritsun T.S., Liapustin V.N., Karganova G.G., Lashkevich V.A. Nonvirion (soluble) antigen of the tick-borne encephalitis virus. Vopr. Virusol. 33:1988;217-227.
56. Gritsun T.S., Lisak V.M., Liapustin N., Korolev M.B., Lashkevich V.A. Slowly-sedimenting hemagglutinin of the tick-borne encephalitis virus. Vopr. Virusol. 34:1989;449-454.
57. Gritsun T.S., Liapustin V.N., Shatalov A.G., Lashkevich V.A. Multiple forms of the NS1 protein as the main component of the nonvirion ("soluble") antigen of the tick-borne encephalitis virus. Vopr. Virusol. 35:1990;471-474.
58. Gritsun T.S., Frolova T.V., Pogodina V., Lashkevich A., Venugopal K., Gould E.A. Nucleotide and deduced amino acid sequence of the envelope gene of the Vasilchenko strain of TBE virus; comparison with other flaviviruses. Virus Res. 27:1993a;201-209.
59. Gritsun T.S., Lashkevich V.A., Gould E.A. Nucleotide and deduced amino acid sequence of the envelope glycoprotein of Omsk haemorrhagic fever virus; comparison with other flaviviruses. J. Gen. Virol. 74:1993b;287-291.
60. Gritsun T.S., Holmes E.C., Gould E.A. Analysis of flavivirus envelope proteins reveals variable domains that reflect their antigenicity and may determine their pathogenesis. Virus Res. 35:1995;307-321.
61. Gritsun T.S., Venugopal K., Zanotto P.M., Mikhailov M.V., Sall A.A., Holmes E.C., Polkinghorne I., Frolova T.V., Pogodina V., Lashkevich A., Gould E.A. Complete sequence of two tick-borne flaviviruses isolated from Siberia and the UK: analysis and significance of the 5′ and 3′-UTRs. Virus Res. 49:1997;27-39.
62. Gritsun T.S., Desai A., Gould E.A. The degree of attenuation of tick-borne encephalitis virus depends on the cumulative effects of point mutations. J. Gen. Virol. 82:2001;1667-1675.
63. Hahn C.S., Dalrymple J.M., Strauss J.H., Rice C.M. Comparison of the virulent Asibi strain of Yellow fever virus with the 17D vaccine strain derived from it. Proc. Natl. Acad. Sci. U.S.A. 84:1987;2019-2023.
64. Heinz F.X. Epitope mapping of flavivirus glycoproteins. Adv. Virus Res. 31:1986;103-168.
65. Heinz F.X., Stiasny K., Puschner Auer G., Holzmann H., Allison S.L., Mandl C.W., Kunz C. Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology. 198:1994;109-117.
66. Heinz F.X., Allison S.L., Stiasny K., Schalich J., Holzmann H., Mandl C.W., Kunz C. Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis. Vaccine. 13:1995;1636-1642.
67. Heinz, F.X., Collett, M.S., Purcell, R.H., Gould, E.A., Howard, C.R., Houghton, M., Moormann, R.J.M., Rice, C.M., Thiel, H.J., 2000. Family Flaviviridae. In: van Regenmortel, M.H.V., Fauquet, C.M., Bishop, D.H.L., Carstens, E., Estes, M.K., Lemon, S., Maniloff, J., Mayo, M.A., McGeogch, D., Pringle, C.R., Wickner, R.B. (Eds.), Virus Taxonomy. In: Proceedings fo the 7th International Committee for the Taxonomy of Viruses. Academic Press, San Diego, CA, pp. 859-878.
68. Holzer G.W., Remp G., Antoine G., Pfleiderer M., Enzersberger O.M., Emsenhuber W., Hammerle T., Gruber F., Urban C., Falkner F.G., Dorner F. Highly efficient induction of protective immunity by a vaccinia virus vector defective in late gene expression. J. Virol. 73:1999;4536-4542.
69. Isachkova L.M., Frolova M.P., Leonova G.N., Karmysheva V., Somov G.P. Pathomorphology of experimental infection caused by Powassan virus isolated in the Primorskii Territory. Vopr. Virusol. 1:1978;68-74.
70. Jacobs S.C., Stephenson J.R., Wilkinson G.W. High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model. J. Virol. 66:1992;2086-2095.
71. Johnson H.N. Isolation of Powassan virus from a spotted skunk in California. J. Wildl. Dis. 23:1987;152-153.
72. Jones L.D., Gaunt M., Hails R.S., Laurenson K., Hudson P.J., Reid H., Henbest P., Gould E.A. Transmission of louping ill virus between infected and uninfected ticks co-feeding on mountain hares. Med. Vet. Entomol. 11:1997;172-176.
73. Kamalov, I.I., Sokolova, E.D., Denisova, E.U., 1989. Prospects of Development of Live Attenuated Vaccine Against Tick-Borne Encephalitis. Tick-Borne Encephalitis, vol. 65. Pasteur Institute of Epidemiology and Microbiology, Leningrad, pp. 98-120.
74. Kamalov I.I., Sokolova E.D., Il'enko I., Rozhkova L.V. A live vaccine against tick-borne encephalitis: the principles of selecting the vaccinal strain. Zh. Mikrobiol. Epidemiol. Immunobiol. 3:1993;70-76.
75. Karabatsos, N., 1980. General characteristics and antigenic relationships. In: Monath, T.P. (Ed.), St. Louis Encephalitis. APHA, Washington, DC, pp. 159-200.
76. Kharitonova, N.N., Leonov, Y.A., 1985. Omsk hemorrhagic Fever. Ecology of the Agent and Epizootiology. Amerind Publishing Co. Pvt. Ltd., New Delhi, 230 pp.
77. Khozinskaya G.A., Chunikhin S.P., Khozinsky V., Stefutkina L.F. Variability of Powassan virus cultured in tissue explants and organism of Hyalomma anatolicum ticks. Acta Virol. 29:1985;305-311.
78. Kislenko G.S., Chunikhin S.P., Rasnitsyn S.P., Kurenkov B., Izotov V.K. Reproduction of Powassan and West Nile viruses in Aedes aegypti mosquitoes and their cell culture. Med. Parazitol. Mosk. 51:1982;13-15.
79. Kobayashi H. Lymphomas and immunological tolerance in the rat induced by murine leukemia viruses. Biol. Haematol. 40:1975;291-300.
80. Kobets N.V., Chernyakhovskaya I.Y., Fontalin L.N. Peculiarities of virus-specific immune response in mice with congenitally acquired influenza infection. Folia Biol. (Praha). 41:1995;295-303.
81. Korenberg E.I., Pchelkina A.A. Multiple viremia in goats following sequential inoculation with tick-borne encephalitis virus. Med. Parazitol. Mosk. 44:1975;181-184.
82. Korenberg E.I., Kovalevskii Y.V. Variation in parameters affecting risk of human disease due to TBE virus. Folia Parasitol. (Praha). 42:1995;307-312.
83. Korenberg E.I., Kovalevskii Y.V. Main features of tick-borne encephalitis eco-epidemiology in Russia. Zentralbl. Bakteriol. 289:1999;525-539.
84. Korenberg E.I., Gorban L.Y., Kovalevskii Y.V., Frizen I., Karavanov A.S. Risk for human tick-borne encephalitis, borrelioses, and double infection in the pre-Ural region of Russia. Emerg. Infect. Dis. 7:2001;459-462.
85. Krugliak S.P., Leonova G.N. The significance of Ixodes ticks in the southern Far East in the circulation of Powassan virus. Vopr. Virusol. 34:1989;358-362.
86. Kulkarni A.B., Mullbacher A., Parrish C.R., Westaway E.G., Coia G., Blanden R.V. Analysis of murine major histocompatibility complex class II-restricted T-cell responses to the flavivirus Kunjin by using vaccinia virus expression. J. Virol. 66:1992;3583-3592.
87. Kunz C., Hofmann H., Stary A. Field studies with a new tick-borne encephalitis (TBE) vaccine. Zentralbl. Bakteriol. Orig. A. 234:1976;141-144.
88. Kunz C., Hofmann H., Heinz F.X., Dippe H. Efficacy of vaccination against tick-borne encephalitis. Wien. Klin. Wochenschr. 92:1980;809-813.
89. Kunz, C. (to be published). TBE vaccination and Austrian experience. Vaccine.
90. Labuda M., Jones L.D., Williams T., Danielova V., Nuttall P.A. Efficient transmission of tick-borne encephalitis virus between cofeeding ticks. J. Med. Entomol. 30:1993;295-299.
91. Labuda M., Jiang W.R., Kaluzova M., Kozuch O., Nuttall P.A., Weismann P., Eleckova E., Zuffova E., Gould E.A. Change in phenotype of tick-borne encephalitis virus following passage in Ixodes ricinus ticks and associated amino acid substitution in the envelope protein. Virus Res. 31:1994;305-315.
92. Labuda M., Austyn J.M., Zuffova E., Kozuch O., Fuchsberger N., Lysy J., Nuttall P.A. Importance of localized skin infection in tick-borne encephalitis virus transmission. Virology. 219:1996;357-366.
93. Labuda M., Kozuch O., Zuffova E., Eleskova E., Hails R.S., Nutall P. Tick-borne encephalitis virus transmission between ticks cofeeding on specific immune natural hosts. Virology. 235:1997;138-143.
94. Leonov V.A., Kogan M., Nekipelova G.A., Vasenin A.A., Shikharbeev B.V. Typifying foci of tick-borne encephalitis in the pre-Baikal. Zh. Mikrobiol. Epidemiol. Immunobiol. 5:1976;56-60.
95. Leonova, G.N., 1997. Tick-Borne Encephalitis in Primorski Region. Dalnauka, Vladivostok, 187 pp.
96. Leonova G.N., Isachkova L.M., Baranov N.I., Krugliak S.P. Role of Powassan virus in the etiological structure of tick-borne encephalitis in the Primorsky Kray. Vopr. Virusol. 2:1980;173-176.
97. Leonova G.N., Krugliak S.P., Lozovskaia S.A., Rybachuk V.N. The role of wild murine rodents in the selection of different strains of tick-borne encephalitis and Powassan viruses. Vopr. Virusol. 32:1987a;591-595.
98. Leonova G.N., Rybachuk V.N., Krugliak S.P., Guliaeva S.E., Baranov N.I. Clinico-epidemiological characteristics of tick-borne encephalitis in the Maritime Territory. Zh. Mikrobiol. Epidemiol. Immunobiol. 12:1987b;40-45.
99. Leonova G.N., Sorokina M.N., Krugliak S.P. The clinico-epidemiological characteristics of Powassan encephalitis in the southern Soviet Far East. Zh. Mikrobiol. Epidemiol. Immunobiol. 3:1991;35-39.
100. Levina L.S., Pogodina V.V. Persistence of the tick-borne encephalitis virus in the vaccinated organism. Vopr. Virusol. 33:1988;485-490.
101. Lindenbach, B.D., Rice, C.M., 2001. Flaviviridae. The viruses and their replication. In: Knippe, D.M., Howley, P.M. (Eds.), Fields Virology, vol. 1. Lippincott Williams & Wilkins, London, New York, Tokyo, pp. 991-1042.
102. Lindgren E., Gustafson R. Tick-borne encephalitis in Sweden and climate change. Lancet. 358:2001;16-18.
103. Lvov, D.K., 1988. Omsk haemorrhagic fever. In: Monath, T.P. (Ed.), The Arboviruses. Epidemiology and Ecology. CRC Press, Boca Raton, FL, pp. 205-216.
104. Lvov D.K., Leonova G.N., Gromashevskii L., Belikova N.P., Berezina L.K. Isolation of the Powassan virus from Haemaphysalis neumanni Donitz, 1905 ticks in the Maritime Territory. Vopr. Virusol. 5:1974;538-541.
105. Malenko G.V., Fokina G.I., Levina L.S., Mamonenko L.L., Rzhakhova O.E., Pogodina V., Frolova M.P. Persistence of tick-borne encephalitis virus IV. Virus localization after intracerebral inoculation. Acta Virol. 26:1982;362-368.
106. Mandl C.W., Heinz F.X., Stockl E., Kunz C. Genome sequence of tick-borne encephalitis virus (Western subtype) and comparative analysis of nonstructural proteins with other flaviviruses. Virology. 173:1989;291-301.
107. Mandl C.W., Holzmann H., Kunz C., Heinz F.X. Complete genomic sequence of Powassan virus: evaluation of genetic elements in tick-borne versus mosquito-borne flaviviruses. Virology. 194:1993;173-184.
108. Mandl C.W., Ecker M., Holzmann H., Kunz C., Heinz F.X. Infectious cDNA clones of tick-borne encephalitis virus European subtype prototypic strain Neudoerfl and high virulence strain Hypr. J. Gen. Virol. 78:1997;1049-1057.
109. Mandl C.W., Holzmann H., Meixner T., Rauscher S., Stadler P.F., Allison S.L., Heinz F.X. Spontaneous and engineered deletions in the 3′ noncoding region of tick-borne encephalitis virus: construction of highly attenuated mutants of a flavivirus. J. Virol. 72:1998;2132-2140.
110. Mandl C.W., Kroschewski H., Allison S.L., Kofler R., Holzmann H., Meixner T., Heinz F.X. Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo. J. Virol. 75:2001;5627-5637.
111. Mahdy, M.S., Wilson, M., Wherrett, B., Dorland, R., 1979. Powassan virus (POWV) encephalitis in Ontario. A case of meningoencephalitis attributed to infection with POWV in eastern Ontario. In: Mahdy, M.S., Spence, L., Joshua, J.M. (Eds.), Arboviral Encephalitides in Ontario with Special Reference to St. Louis Encephalitis, Ministry of Health, Ontario, pp. 48-67.
112. Marin M.S., McKenzie J., Gao G.F., Reid H.W., Antoniadis A., Gould E.A. The virus causing encephalomyelitis in sheep in Spain: a new member of the tick-borne encephalitis group. Res. Vet Sci. 58:1995;11-13.
113. Mauracher C.A., Mitchell L.A., Tingle A.J. Selective tolerance to the E1 protein of rubella virus in congenital rubella syndrome. J. Immunol. 151:1993;2041-2049.
114. Monath T.P., Soike K., Levenbook I., Zhang Z.X., Arroyo J., Delagrave S., Myers G., Barrett A.D., Shope R.E., Ratterree M., Chambers T.J., Guirakhoo F. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates. Vaccine. 17:1999;1869-1882.
115. Monath T.P., Levenbook I., Soike K., Zhang Z.X., Ratterree M., Draper K., Barrett A.D., Nichols R., Weltzin R., Arroyo J., Guirakhoo F. Chimeric Yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys. J. Virol. 74:2000;1742-1751.
116. Murphy, F., 1980. Togavirus morphology and morphogenesis. In: Schlesinger, R.W. (Ed.), The Togaviruses. Biology, Structure, Replication. Academic Press, New York, pp. 241-316.
117. Nuttall P.A., Jones L.D., Labuda M., Kaufman W.R. Adaptations of arboviruses to ticks. J. Med. Entomol. 31:1994;1-9.
118. Oldstone M.B. Viral persistence: mechanisms and consequences. Curr. Opin. Microbiol. 1:1998;436-441.
119. Ormaasen V., Brantsaeter A.B., Moen E.W. Tick-borne encephalitis in Norway. Tidsskr. Nor Laegeforen. 121:2001;807-809.
120. Pletnev A.G. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3′ deletion mutant constructed from it exhibits decreased neuroinvasiveness in immunodeficient mice. Virology. 282:2001;288-300.
121. Pletnev A.G., Yamshchikov V.F., Blinov V.M. Nucleotide sequence of the genome and complete amino acid sequence of the polyprotein of tick-borne encephalitis virus. Virology. 174:1990;250-263.
122. Pletnev A.G., Bray M., Huggins J., Lai C.J. Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses. Proc. Natl. Acad. Sci. U.S.A. 89:1992;10532-10536.
123. Pletnev A.G., Karganova G.G., Dzhivanyan T.I., Lashkevich A., Bray M. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus. Virology. 274:2000;26-31.
124. Pletnev A.G., Bray M., Hanley K.A., Speicher J., Elkins R. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes. J. Virol. 75:2001;8259-8267.
125. Pogodina V. The resistance of tick-borne encephalitis virus to the effects of gastric juice. Vopr. Virusol. 3:1958;295-299.
126. Pogodina V. Experimental study of the pathogenesis of tick-borne encephalitis on alimentary infection. II. Study of pathways of excretion of virus from white mice. Probl. Virol. 5:1960;304-310.
127. Pogodina V., Bochkova N.G., Koreshkova G.V. Strain properties of the Aina/1448 serotype of the tick-borne encephalitis virus. Vopr. Virusol. 6:1981a;741-746.
128. Pogodina V., Frolova M.P., Malenko G.V., Fokina G.I., Levina L.S., Mamonenko L.L., Koreshkova G.V., Ralf N.M. Persistence of tick-borne encephalitis virus in monkeys. I. Features of experimental infection. Acta Virol. 25:1981b;337-343.
129. Pogodina V., Levina L.S., Fokina G.I., Koreshkova G.V., Malenko G.V., Bochkova N.G., Rzhakhova O.E. Persistence of tick-borne encephalitis virus in monkeys. III. Phenotypes of the persisting virus. Acta Virol. 25:1981c;352-360.
130. Pogodina V., Malenko G.V., Fokina G.I., Levina L.S., Koreshkova G.V., Rzhakhova O.E., Bochkova N.G., Mamonenko L.L. Persistence of tick-borne encephalitis virus in monkeys. II. Effectiveness of methods used for virus detection. Acta Virol. 25:1981d;344-351.
131. Pogodina, V., Frolova, M.P., Erman, B.A., 1986. Chronic Tick-Borne Encephalitis. Nauka, Moscow.
132. Pogodina V., Bochkova N.G., Dzhivanian T.I., Levina L.S., Karganova G.G., Riasova R.A., Sergeeva A., Lashkevich V.A. The phenomenon of antigenic defectiveness in naturally circulating strains of the tick-borne encephalitis virus and its possible connection to seronegative forms of the disease. Vopr. Virusol. 37:1992;103-107.
133. Popov F., Ivanova L.M. Epidemiologic features of the alimentary route of infection of tick-borne encephalitis in the RSFSR territory. Zh. Mikrobiol. Epidemiol. Immunobiol. 45:1968;36-42.
134. Porterfield J.S. The basis of arbovirus classification. Med. Biol. 53:1975;400-405.
135. Proutski V., Gaunt M.W., Gould E.A., Holmes E.C. Secondary structure of the 3′-untranslated region of Yellow fever virus: implications for virulence, attenuation and vaccine development. J. Gen. Virol. 78:1997a;1543-1549.
136. Proutski V., Gould E.A., Holmes E.C. Secondary structure of the 3′ untranslated region of flaviviruses: similarities and differences. Nucleic Acids Res. 25:1997b;1194-1202.
137. Ramakrishna C., Desai A., Shankar S.K., Chandramuki A., Ravi V. Oral immunisation of mice with live Japanese encephalitis virus induces a protective immune response. Vaccine. 17:1999;3102-3108.
138. Randolph S.E., Miklisova D., Lysy J., Rogers D.J., Labuda M. Incidence from coincidence: patterns of tick infestations on rodents facilitate transmission of tick-borne encephalitis virus. Parasitology. 118:1999;177-186.
139. Rauscher S., Flamm C., Mandl C.W., Heinz F.X., Stadler P.F. Secondary structure of the 3′-noncoding region of flavivirus genomes: comparative analysis of base pairing probabilities. RNA. 3:1997;779-791.
140. Reid H.W., Boyce J.B. Louping-ill virus in red grouse in Scotland. Vet. Rec. 95:1974;150.
141. Rey F.A., Heinz F.X., Mandl C., Kunz C., Harrison S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature. 375:1995;291-298.
142. Rice C.M., Lenches E.M., Eddy S.R., Shin S.J., Sheets R.L., Strauss J.H. Nucleotide sequence of Yellow fever virus: implications for flavivirus gene expression and evolution. Science. 229:1985;726-733.
143. Roggendorf M., Goldhofer E., Heinz F.X., Epp C., Deinhardt F. Epidemiology of tick-borne encephalitis in Southern Germany. MMW Munch. Med. Wochenschr. 123:1981;1407-1411.
144. Russell, P.K., Brandt, W.E., Dalrymple, J.M., 1980. Chemical and antigenic structure of flaviviruses. In: Schlesinger, R.W. (Ed.), The Togaviruses: Biology, Structure, Replication. Academic Press, New York.
145. Safronov P.F., Netesov S.V., Mikriukova T.P., Blinov M., Osipova E.G., Kiseleva N.N., Sandakhchiev L.S. Nucleotide sequence of genes and complete amino acid sequence of tick-borne encephalitis virus strain 205. Mol. Gen. Mikrobiol. Virusol. 4:1991;23-29.
146. Scherer W.F., Eddy G.A., Monath T.P., Walton T.E. Laboratory safety for arboviruses and certain other viruses of vertebrates. Am. J. Trop. Med. Hyg. 29:1980;1359-1381.
147. Schlesinger J.J., Brandriss M.W., Cropp C.B., Monath T.P. Protection against yellow fever in monkeys by immunization with Yellow fever virus nonstructural protein NS1. J. Virol. 60:1986;1153-1155.
148. Schmaljohn C., Vanderzanden L., Bray M., Custer D., Meyer B., Li D., Rossi C., Fuller D., Fuller J., Haynes J., Huggins J. Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge. J. Virol. 71:1997;9563-9569.
149. Schmaljohn C., Custer D., VanderZanden L., Spik K., Rossi C., Bray M. Evaluation of tick-borne encephalitis DNA vaccines in monkeys. Virology. 263:1999;166-174.
150. Seto A., Kawanishi M., Matsuda S., Ogawa K. Seronegative virus carriers in the infection of rabbits with human T lymphotropic virus type I. J. Exp. Med. 168:1988;2409-2414.
151. Sevilla N., Kunz S., Holz A., Lewicki H., Homann D., Yamada H., Campbell Kevin P., de la Torre Juan C., Oldstone Michael B.A. Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J. Exp. Med. 192:2000;1249-1260.
152. Shapoval, A.N., 1955. To the problem of recidivation of tick-borne encephalitis. In: Proceedings of Interregional Conference of Medics of ASSR, Ural, Siberia and Far East, pp. 18-20.
153. Shapoval, A.N., 1976. Chronic Forms of Tick-Borne Encephalitis. Medicine, Leningrad, 175 pp.
154. Shapoval, A.N., 1977. The Prophylaxis of Tick-Borne Encephalitis. Medicine, Moscow, 47 pp.
155. Shapoval, A.N., 1989. The Outbreaks of Tick-Borne Encephalitis in Karelia and their Significance for Studies of Disease. Tick-Borne Encephalitis, vol. 65. Pasteur Institute of Epidemiology and Microbiology, Leningrad, pp. 49-56.
156. Shapoval, A.N., Kamalov, I.I., Denisova, E.I., Sokolova, E.D., Luzin, P.M., Shamarina, A.G., Gusmanova, A.G., Pinaeva, N.I., 1989. Study of the distant consequences of immunizing people with a live vaccine against tick-borne encephalitis. In: Noscov, F.C. (Ed.), Tick-borne Encephalitis, vol. 65. Pasteur Institute of Epidemiology and Microbiology, Leningrad, pp. 49-55.
157. Smith G.C. A virus resembling Russian spring-summer encephalitis virus fron tan Ixodid in Malaya. Nature. 178:1956;5851-5852.
158. Smorodintsev, A.A., 1954. Neuroviral Infections. Medgiz, Leningrad, 340 pp.
159. Smorodintsev, A.A., Dubov, A.V., 1986. Tick-Borne Encephalitis and Its Vaccino-Prophylaxis. Medicine, Moscow, 230 pp.
160. Sokolova E.D., Kamalov I.I., Konovalov G.V., Veigman N.Z. The neurovirulence of variants of the Langat TP-21 virus in experiments on different species of lower monkeys. Vopr. Virusol. 39:1994a;116-119.
161. Sokolova E.D., Kamalov I.I., Konovalov G.V. Characteristics of neurovirulence, stability, and immunogenicity of attenuated variants of TP-21 Langat virus. Vopr. Virusol. 39:1994b;220-223.
162. Timoney P.J. Recovery of louping ill virus from the red grouse in Ireland. Br. Vet. J. 128:1972;19-23.
163. Venugopal K., Gritsun T., Lashkevich A., Gould E.A. Analysis of the structural protein gene sequence shows Kyasanur Forest disease virus as a distinct member in the tick-borne encephalitis virus serocomplex. J. Gen. Virol. 75:1994;227-232.
164. Vereta L.A., Skorobrekha V.Z., Nikolaeva S.P., Aleksandrov I., Tolstonogova I., Zakharycheva T.A., Red'ko A.P., Lev M.I., Savel'eva N.A. The transmission of the tick-borne encephalitis virus via cow's milk. Med. Parazitol. Mosk. 3:1991;54-56.
165. Vorob'eva M.S., Rasshchepkina M.N., Ladyzhenskaia I.P., Gorbunov M.A., Pavlova L.I., Bektimirov T.A. Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the "Immuno" firm. Vopr. Virusol. 41:1996;221-224.
166. Votiakov I., Protas I.I., Bortkevich S., Nedz'ved M.K. Experimental study of the pathogenesis of tick-borne encephalitis. Vopr. Virusol. 3:1975;313-317.
167. Votiakov, I., Protas, I.I., Zhdanov, V.M., 1978. Western Tick-Borne Encephalitis. Belarus, Minsk, 256 pp.
168. Wallner G., Mandl C.W., Kunz C., Heinz F.X. The flavivirus 3′-noncoding region: extensive size heterogeneity independent of evolutionary relationships among strains of tick-borne encephalitis virus. Virology. 213:1995;169-178.
169. Wallner G., Mandl C.W., Ecker M., Holzmann H., Stiasny K., Kunz C., Heinz F.X. Characterization and complete genome sequences of high- and low-virulence variants of tick-borne encephalitis virus. J. Gen. Virol. 77:1996;1035-1042.
170. Watts A.M., Stanley J.R., Shearer M.H., Hefty P.S., Kennedy R.C. Fetal immunization of baboons induces a fetal-specific antibody response. Nat. Med. 5:1999;427-430.
171. Wills M.R., Singh B.K., Debnath N.C., Barrett A.D. Immunogenicity of wild-type and vaccine strains of Japanese encephalitis virus and the effect of haplotype restriction on murine immune responses. Vaccine. 11:1993;761-766.
172. Winkler G., Randolph V.B., Cleaves G.R., Ryan T.E., Stollar V. Evidence that the mature form of the flavivirus nonstructural protein NS1 is a dimer. Virology. 162:1988;187-196.
173. Wohlsein P., Trautwein G., Depner K.R., Hubschle O.J., Liess B. Pathomorphological and immunohistological findings in progeny of goats experimentally infected with pestiviruses. Zentralbl. Veterinarmed. 39:1992;1-9.
174. Woodall J.P., Roz A. Experimental milk-borne transmission of Powassan virus in the goat. Am. J. Trop. Med. Hyg. 26:1977;190-192.
175. Work T.H., Trapido H. Kyasanur Forest disease, a new virus disease in India. Ind. J. Med. Sci. 11:1957;341-345.
176. Xie H., Ryman K.D., Campbell G.A., Barrett A.D. Mutation in NS5 protein attenuates mouse neurovirulence of yellow fever 17D vaccine virus. J. Gen. Virol. 79:1998;1895-1899.
177. Xin Y.Y., Ming Z.G., Peng G.Y., Jian A., Min L.H. Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children. Am. J. Trop. Med. Hyg. 39:1988;214-217.
178. Zanotto P.M., Gao G.F., Gritsun T., Marin M.S., Jiang W.R., Venugopal K., Reid H.W., Gould E.A. An arbovirus cline across the northern hemisphere. Virology. 210:1995;152-159.
179. Zanotto P.M., Gibbs M.J., Gould E.A., Holmes E.C. A reevaluation of the higher taxonomy of viruses based on RNA polymerases. J. Virol. 70:1996a;6083-6096.
180. Zanotto P.M., Gould E.A., Gao G.F., Harvey P.H., Holmes E.C. Population dynamics of flaviviruses revealed by molecular phylogenies. Proc. Natl. Acad. Sci. U.S.A. 93:1996b;548-553.
181. Zeng L., Kurane I., Okamoto Y., Ennis F.A., Brinton M.A. Identification of amino acids involved in recognition by dengue virus NS3-specific, HLA-DR15-restricted cytotoxic CD4+ T-cell clones. J. Virol. 70:1996;3108-3117.
182. Zlobin, I., Gorin, O.Z., 1996. Tick-Borne Encephalitis: Etiology, Epidemiology and Prophylactics in Siberia. Nauka, Novosibirsk, 177 pp.